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OBJECTIVE: Most symptomatic chronic subdural hematomas are treated by subdural drainage. 
In contrast, a subperiostal, i.e. extracranial, passive closed-drainage system in combination with 
two burr-hole trepanation is used at our institution. We therefore wanted to analyze our results and 
compare them to alternate treatment strategies reported in the current literature. 
METHODS: In a retrospective single centre study we analyzed the data of all patients 
undergoing two-burr-hole trepanation with a subperiostal passive closed-drainage system. 
Data analysis included general patient data, complications, postoperative seizure rate and 
outcome. 
RESULTS: 147 patients underwent surgery for 183 SCSH. Perioperative mortality was 3.4 
%. Hematoma persistence or recurrence occurred in 13.1 % of cases. Post-operative seizure 
rate was 6.6 % and the infection rate 1.6 %, including 3 cases of superficial wound infection, 
and 1 case with deep infection. Re-intervention rate was 9.3 %, including trepanation in 8.2 
%, and craniotomy in 1.1 %. The overall complication rate was 10.9 %. 
CONCLUSION: Two-burr-hole trepanation with subperiostal passive closed-drainage 
system is a technically easy, highly effective, safe, and cost-efficient treatment strategy for 
SCSH. The absence of a drain in direct contact with the hematoma capsule may moderate the 
risk of post-operative seizure, and limits the secondary spread of infection to intracranial 
compartments. 
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Introduction 
Symptomatic chronic subdural hematomas (SCSH) are common in neurosurgical 
practice. They are found primarily in the elderly (1, 2). Clinical history generally includes 
mild to moderate head trauma (2, 8). Other main risk factors comprise alcohol abuse, cephalo-
spinal fluid shunts, antiplatelet agents, coagulopathies, and therapeutic anticoagulation (2, 15, 
33). For asymptomatic chronic subdural hematomas, treatment options reported in the 
literature include conservative neurological surveillance combined with bed rest and 
corticosteroid therapy (27). Surgery is generally recommended when chronic subdural 
hematomas become symptomatic. The optimal surgical procedure, the use of a closed-
drainage system, and modalities of post-operative management are under ongoing debate (1, 
3, 9, 12, 14, 25, 34, 37). Complications of surgery mainly include infection, acute 
hemorrhage, post-operative seizure, symptomatic hygroma, and symptomatic 
pneumocephalus (16, 22, 29). 
  Surgical methods proposed in recent literature mainly include twist-drill craniostomy, 
burr-hole trepanation, and multiple variants of craniotomy (10, 17, 21, 23, 31, 36). At present, 
burr-hole surgery with subdural closed-drainage system is the most commonly chosen 
strategy. This technique was repeatedly shown to be effective and safe (7, 8, 14, 18, 20, 22, 
23, 32, 34, 36, 37). More recently, enlarged single-burr-hole trepanation in combination with 
a suction-assisted subgaleal draining system has also earned consideration as a safe and 
effective approach (7).  
In the present article, we analyze our 5-year experience with two-burr-hole trepanation 
combined with a subperiostal, i.e. extracranial, non-aspiring draining system. We argue about 
the importance and modalities of post-operative medical management. By comparing our 
series to alternate techniques published so far, we illustrate the effectiveness and safety of the 
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technique where there is no contact of the drain with the fragile subdural membranes, brain 
surface or bridging veins as it is inserted in a subperiostal fashion. 
Patients and Methods 
General features:  
We retrospectively reviewed data of all consecutive patients who underwent surgery 
for SCSH in the Centre Hospitalier Universitaire Vaudois (CHUV) between January 2002 and 
January 2007. General patient information was collected, including patients’ age, sex, and 
specific risk factors. The pre-operative Glasgow Coma Scale (GCS) score, and relevant 
neurological findings were noted. The main clinical finding that motivated subsequent surgery 
was also determined. CT scan protocols were reviewed regarding the side of the hematoma, 
and whether the hematoma was uni-or bilateral. Surgery protocols were inspected regarding 
the side of trepanation, and whether the trepanation was uni- or bilateral. All peri-operative 
complications were further investigated. In case of post-operative infection, we differentiated 
between superficial, thus extracranial infections, and deep, subdural or intraparenchymal 
infection. Detection of hematoma recurrence was based on a daily neurological examination, 
and subsequently confirmed by CT scanning. In those cases where hematoma persistence or 
recurrence was identified, we determined the type of second intention treatment applied. 
Hospitalization protocols were examined regarding the duration of hospitalization and the 
patient orientation at discharge. Finally, outcome was evaluated on the basis of a routine 
clinical assessment 3 months after surgery that included determination of the Glasgow 
Outcome Scale (GOS) score (11). 
Clinical management:  
A standard treatment protocol was applied to all cases. Pre-operative management 
included medical normalization of the coagulation parameters, and platelet substitution in the 
presence of antiplatelet drugs. Surgery was generally performed under general anesthesia. 
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Local anesthesia procedure was restricted to a few cases in which general anesthesia appeared 
to be too risky from the Anesthetics point of view. During surgery patients were in supine 
position, the head elevated and rotated 20° to the opposite side of the hematoma. A single-
dose prophylactic antibiotic was given just prior to the skin incision. Surgery consisted of two 
burr-holes made above the superior temporal line according to the preoperative CT-scan. The 
dura was incised and coagulated by bipolar coagulation. The outer membrane of the 
hematoma was first coagulated and then divided. The hematoma cavity was washed through 
both burr-holes using continuous irrigation by body-tempered, isotonic saline solution until 
clear fluid came out of both burr-holes. The brain surface was visualized through both burr-
holes. A Redon drain (8 Ch. B. Braun Medical AG, Melsungen, Germany) was then inserted 
through the frontal skin incision and positioned under the periosteum, epicranially from 
frontal to parietal, thus leaving the draining holes over both burr-holes (Figure). The posterior 
incision was closed first allowing the hematoma cavity to be filled with saline solution prior 
to the closing of the anterior incision. Prior to connecting the redon drain to the container 
(Redovac, B. Braun Medical AG, Melsungen, Germany), the container was perforated on its 
top surface by a sterile needle. The needle was left in place allowing continuous pressure 
neutralization during the container’s progressive filling with washing solution and remaining 
subdural blood. 
Regarding postoperative management, the standard procedure included keeping the 
patient at flat bed-reds for 48h. The draining system was fixed to the bed’s frame about 20 cm 
under the level of the epicantus. Mild intravenous hyperhydratation with 2500cc/24h of 
glucosaline solution (GlucoSaline 2:1; B. Braun Medical AG, Melsungen, Germany) for 48 
hours was performed. Compression boots were used during this period. Anti-epileptic 
prophylaxis with a single loading dose of phenytoin was started during surgery. Anti-
epileptic medication was only continued in the presence of at least 1 seizure. At 48 hours, the 
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draining system was systematically removed, patients were mobilized, and low dose heparin 
prophylaxis was introduced. Post-operative CT scanning was restricted to those cases where 
the daily clinical exam showed evidence of complication. A standardized post-operative 
physiotherapeutic evaluation determined if the patient was discharged, or transferred to a 
rehabilitations institution. In the presence of forgoing medical investigation or therapy that did 
not require neurosurgical knowledge, the patients were commonly transferred to the referring 
hospital.  
Follow-up: All patients underwent a routine clinical assessment 3 months after surgery. 
Routine clinical assessment included history taking and neurological examination with special 
focus on lateralization signs such as pronator drift and speech impairment.  The GOS score 
was determined on the basis of the obtained information. In the presence of persistent 
complaints or recurrent relevant clinical findings, further investigations including a head CT 
scan were performed.  
 
Results 
General features:  
A total of 147 consecutive adult patients with a mean age of 71.5 years (range 42 to 93 
years) and a male predominance of 76.9 % were found in our operative database and included 
in the present study. Thirty-six (24.5%) of these patients presented with bilateral SCSH. A 
total of 183 hemispheres were thus trepanated. History taking revealed past mild or moderate 
head trauma in 117 patients (79.6 %). Other risk factors included oral anticoagulation or anti-
coagulating disease in 27.9 %, taking of antiplatelet drugs in 25.1 %, and chronic alcohol 
abuse in 12.2 %. The indication for surgery was mainly based on the discovery of progressive 
neurological deficits. Findings included unilateral weakness in 61.9 %, acute state of 
confusion in 10.8 %, and decreasing level of consciousness in 8.2 %. Other indications for 
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surgery included harsh headache in 6.8 %, imbalance resulting in spontaneous falls in 4.8 %, 
inaugural seizure in 2.7 %, diffuse neuropsychological findings in 2 %, and aphasic disorders 
in 1.4 %. Details are given in Table 1. 
Surgical procedure: 
Unilateral two-burr-hole trepanation was performed in a total of 111 cases (75.5 %), 
from which 71 (48.3%) were left-sided, and 40 (27.2%) were right-side-only procedures. 
Bilateral trepanation in one session was done in the remaining 36 cases (24.5 %) (Table 2).  
Outcome:  
The GOS score at 3 months follow-up was 5 in 108 patients (73.5%), 4 in 28 patients 
(19%), 3 in 5 patients (3.4%), 2 in 1 patient (0.7%) and 1 in 5 patients (3.4%). The mean 
duration of hospitalization was 8.8 days (range 3 to 36 days). Patients were discharged 
without particular ongoing medical measures in 48.3 %, and 15.6% were referred to a 
rehabilitation clinic for reason of persistent neurological deficits. The remaining 32.7 % were 
transferred to the referring hospital for non-neurosurgical medical investigations and therapy.  
Hematoma persistence or recurrence confirmed by CT scans occurred in 22 patients 
(15%) or 24 operated sides (13.1%). Recurrence was defined as the reappearance of relevant 
neurological deficits. Second intention procedure was performed in 17 patients (11.6%). This 
comprised re-trepanation in 15 patients (10.2%) and craniotomy in 2 patients (1.4 %). Second 
intention trepanation was applied to all cases with documented symptomatic recurrence. All 
patients with documented but asymptomatic persistence (3.4 %) underwent conservative 
therapy.  
Complications:  
The overall complication rate was 10.9 % per operated side. The intraoperative 
mortality was 0.7 %, and the perioperative mortality was 3.4 %. Of the 5 patients who expired 
during hospitalization, two patients continued to bleed acutely from subdural membranes 
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despite trepanation. The decision to stay away from a second intervention was taken on the 
basis of the patients’ general health condition and the patients’ age. One patient with severe 
coagulopathy developed post-operative epidural bleeding and expired despite craniotomy. 
One patient developed cardiac arrest during surgery, but before trepanation could be done. He 
finally expired from therapy-refractory pulmonary failure. One patient developed severe 
atelectasy in the post-operative phase and expired from cardio-pulmonary failure despite 
intensive respiratory therapy. 
Infection occurred in 3 patients (2 %) and 1.6% of the operated sides. Two patients 
(1.4 %) with superficial wound infection underwent superficial wound revision in addition to 
intravenous antibiotic therapy. In one case (0.7 %), deep infection developed one week after 
surgery, which needed craniotomy to evacuate the subdural empyema built up on the side of 
the initial burr-hole trepanation. 
The incidence of documented post-operative seizure was 7.4 %. The onset of seizure 
was within 72 hours of surgery in all cases. No case of symptomatic pneumocephalus, and no 
complications due to traumatic handling of the drain were reported.  
 
Discussion 
Treatment of SCSH should be effective, safe, technically easy, and cost-efficient. Most 
surgical strategies include the use of a draining system with the catheter tip inserted into the 
subdural space. The aim of this practice is to allow brain re-expansion through progressive 
evacuation of rinsing fluid and residual subdural blood. In the present series, the drain was 
inserted epicranially under the periosteum leaving the draining holes over both burr-holes 
(Figure). In accordance with Gazzeri et al. (7), the extracranial placement of the drain allows 
equally efficient resorption of rinsage liquid and remaining subdural blood as long as the dura 
is not sealed during surgery. In contrast to the last-named authors, the choice of a two-burr-
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hole strategy allowed us to pass up active peri-operative draining methods. It also allowed us 
to stay away from hazardous enlargement of the burr-holes.  
Good outcome results from low perioperative mortality and low postoperative 
morbidity. In the literature, mortality during hospitalization for SCSH reaches from 5 to 13.3 
% (28, 29, 31). In the present study, the perioperative mortality was 3.4 % with fatal outcome 
in a total of 5 cases. Only 3 patients expired from direct surgical complications (two patients 
continued to bleed from subdural membranes despite trepanation, and one patient developed 
immediate post-operative epidural bleeding). Moreover, only 1 patient succumbed to 
pulmonary failure eventually in relation with our post-operative management strategy. 
Regarding morbidity, few reliable data are available in the literature. In the present study, 
mean GOS showed good outcome (GOS 4 and 5) in 92.5% at 3 months follow-up. This result 
has to been considered in light of the patients’ mean age of 71.5 years, and the high 
prevalence of comorbidities. It thus plainly illustrates how good functional outcome can be 
achieved by the presented strategy.  
In the present series, the rate of documented hematoma persistence or recurrence was 
13.1 %. Surgical re-intervention was limited to those 9.3 % who became clinically manifest. 
In the literature, re-intervention rates after burr-hole surgery with subdural drains vary 
between 8.3 and 26.5 % (5, 6, 14, 19, 20, 24, 35). Results from the present series, and 7.6 % 
obtained by the akin strategy reported by Gazzeri et al. (7), thus represent comparatively low 
incidences of recurrence. Moreover, classic procedures are followed in up to 8 % by tension 
pneumocephalus (16, 22, 30). In the present series, as in the series reported by Gazzeri et al. 
(7), no case of symptomatic pneumocephalus was reported. Extracranial placement of the 
drain is thus within range of traditional subdural locations in terms of recurrence prevention. 
Whereas Gazzeri et al. (7) combined the subgaleal insertion of the drain with an active suction 
device, a purely passive closed-draining system was used in the present series.  
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Regarding infection rates, literature review reveals that post-operative empyema 
occurs in about 2 % (26, 29) with classic methods. Even though the cumulative post-operative 
infection rate was 1.6 % in the present series, post-operative deep brain structures infection 
occurred in only 1 operated side (0.5 %). Gazzeri et al. (7) similarly reported a very low 
incidence of post-operative deep infection in relation with extracranial placement of the drain. 
The absence of foreign material in direct contact with intracranial structures thus possibly 
limits the propagation of infection agents into deep compartments, and thus potentially 
moderates the formation of deleterious secondary empyema. Even though it appears tempting 
and reasonable to lower the incidence of deep brain infection by choosing non-irritant surgical 
methods such as extracranial drains, large-scale studies will be necessary to fully elucidate 
this matter of importance as the available literature is limited in its statistically significance by 
a too low numbers of patients to demonstrate this effect.  
Post-operative seizure in SCSH is reported to occur in 7 to 13.7 % (4, 13, 29). Kotwica 
et al. (13) suggested that the capsule of the hematoma might play an important role in its 
occurrence. In the present study, post-operative inaugural seizure was noted in 8.2 % of 
patients and 6.6 % of operated sides. This comparatively low incidence may corroborate the 
theory from Gazzeri et al. (7) stipulating that the absence of an irritating drain in direct 
contact with the hematoma capsule moderates the risk of seizure during the phase of brain re-
expansion. In light of our experience, we recommend to limit antiepileptic prophylaxis to a 
single loading dose of Phenytoin before the end of surgery. This approach not only allowed us 
to obtain comparatively low incidence of early post-operative seizure, but also limited the 
occurrence of local or systemic side effects of commonly used anti-epileptic therapies. 
Comparisons between series are limited so far as there is no clear consent in the literature 
regarding indication and modalities of perioperative anti-epileptic coverage (4, 13, 29). 
Prospective randomized trials will thus be necessary to determine if the absence of an 
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irritating drain in contact with the hematoma capsule consistently reduces the incidence of 
post-operative seizure. Meanwhile, potentially lowering its incidence by the use of non-
irritant surgical methods such as extracranial drains appears as a promising and reasonable 
approach. 
Concerning safety, no complications related to traumatic handling of a subperiostal 
drain was reported in the present series. In our experience, the insertion of the drain under the 
periosteum is particularly trouble-free as no manipulation of intracranial structures is 
necessary. Moreover, patient-care is simplified as accidental traumatic removal of the drains 
bears very limited risk of subsequent intra-cranial hemorrhage.  
Prevention of hematoma recurrence and reduction of post-operative hygroma 
formation results not only from efficient hematoma drainage, but also depends on post-
operative management that actively promotes adequate brain re-expansion. We therefore 
advocate a significant period of flat bed rest in combination with mild intravenous 
hyperhydratation. Abouzari et al. (1) recently reported that these measures significantly 
prevent recurrence in comparison to semi-sitting position at 30-40 degrees. The same authors 
showed that post-operative flat bed-rest does not significantly increase the pulmonary 
complication rate. In the present study, severe atelectasy with subsequent pulmonary 
decompensation occurred in one single case. Compression boots were routinely used to 
prevent thrombo-embolic complications during the phase of flat bed rest.   
Regarding cost-effectiveness, active avoidance of complications should be associated 
with early discharge. Few data regarding patient orientation after burr-hole trepanation are 
available in the literature. In the present series, virtually half of all patients (48.3 %) were 
discharged without particular medical measures after a mean hospitalization time of 8.8 days.  
 
Conclusions 
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 Two-burr-holes trepanation in combination with a subperiostal non-aspiring draining 
system is an effective, safe, technically easy, and cost-efficient treatment strategy for SCSH. 
Rates of complications are well within range of studies advocating other forms or treatment. 
The most evident advantage of the method is its technical ease and safety. In contrast to other 
methods, this strategy passes up hazardous enlargement of burr-holes and stays away from 
delicate active draining systems. Patient safety is improved as traumatic handling of the drains 
does not bear the risk of either injuring subdural membranes leading to secondary bleeding, or 
harming brain parenchyma directly. As no foreign material comes into direct contact with 
intracranial structures, potential advantages include low incidence of deep infection and 
limitation of postoperative seizure. As statistical comparisons between series are limited so far 
due to variable perioperative medical seizure prevention and due to low numbers of infection, 
large-scale prospective randomized trials will be required to confirm these results. 
Meanwhile, potentially lowering the incidence of deep infections and early seizures by using 
a non-irritant surgical method appears most promising and reasonable. In the present study, 
cost-effectiveness was achieved through good functional outcome, low incidence of 
complications, and therefore short duration of hospitalization. 
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Figure: Illustration of the surgical technique, showing the epicranially inserted, drain which is 
placed under the periosteum with the draining holes over both burr-holes. As the dura is not 
sealed during surgery, the subperiostal placement of the drain allows efficient draining of the 
remaining subdural fluid.  
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Table 1: General data of 147 patients treated for 183 symptomatic chronic subdural 
hematomas by burr hole trepanation and subperiostal drainage  
Study Characteristics  
Period taken into account 5 years 
Number of symptomatic chronic subdural hematoma (SCSH) treated 183  
 
Patient Characteristics Number of Patients 
N=147 (%) 
Consecutive Patients 147 (100) 
   - Unilateral SCSH 111 (75.5) 
   - Bilateral SCSH 36 (24.5) 
Age 42-93y (mean 71.5) 
Sex distribution (male proportion) 113 (76.9) 
Patients under oral anticoagulation or anticoagulation disease 41 (27.9) 
Patients taking antiplatelet medication 37 (25.2) 
Patients being known for chronic alcohol abuse 18 (12.2) 
History of head trauma 117 (79.6) 
Presenting sensitive-motor lateralization signs prior to surgery 107 (72.8) 
 
Indication for surgery  
   - Hemisyndrome 93 (63.3) 
   - Acute state of confusion 16 (10.9) 
   - Decreased level of consciousness 12 (8.2) 
   - Headache 10 (6.8) 
   - Imbalance resulting in spontaneous falls 7 (4.8) 
   - Inaugural seizure 4 (2.7) 
   - Diffuse neuropsychological deficits 3 (2) 
   - Language disorder 2 (1.4) 
 
Hospitalization characteristics  
Mean duration of Hospitalization 8.8 days 
Discharged home after surgery 71 (48.3) 
Transferred to regional hospital 48 (32.7) 
Transferred to rehab clinic 23 (15.6) 
Expired during Hospitalization 5 (3.4) 
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Table 2: Results of 147 patients treated for 183 symptomatic chronic subdural hematomas by 
subperiostal drainage 
 per patient 
N=147 (%) 
per trepanation 
N=183 (%) 
Surgical characteristics   
Bilateral trepanation 36 (24.5)  
Left side trepanation 71 (48.3)  
Right side trepanation 40 (27.2)  
 
Complications   
Total complications 20 (13.6) 20 (10.9) 
Perioperative Mortality 5 (3.4) 5 (2.7) 
   - Intraoperative Mortality 1 (0.7) 1 (0.5) 
   - Pulmonary decompensation 1 (0.7) 1 (0.5) 
   - Refractory subdural bleeding 2 (1.4) 2 (1.1) 
   - Acute epidural bleeding 1 (0.7) 1 (0.5) 
Infection rate 3 (2) 3 (1.6) 
   - Superficial infection 2 (1.4) 2 (1.1) 
   - Deep infection (empyema) 1 (0.7) 1 (0.5) 
Postoperative seizure rate 12 (8.2) 12 (6.6) 
 
Recurrence   
Total recurrence / persistence 22 (15) 24 (13.1)* 
 
Second intention procedure   
Reoperation 17 (11.6) 17 (9.3) 
   - Second trepanation 15 (10.2) 15 (8.2) 
   - Craniotomy 2 (1.4) 2 (1.1) 
Conservative treatment 5 (3.4) 7 (3.8) 
   
Outcome  
Mean GCS at admission 14.2 
Mean GCS at discharge 14.8 
GOS at follow-up Patients, N=147 (%) 
   - GOS 5 108 (73.5) 
   - GOS 4 28 (19) 
   - GOS 3 5 (3.4) 
   - GOS 2 1 (0.7) 
   - GOS1 5 (3.4) 
 
 
 
 
 
 
